ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 G
about
Dysregulation of histone acetyltransferases and deacetylases in cardiovascular diseasesErythropoiesis-stimulating agents for anaemia in chronic heart failure patientsA study to assess the effects of a broad-spectrum immune modulatory therapy on mortality and morbidity in patients with chronic heart failure: the ACCLAIM trial rationale and designNO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potentialExercise-based cardiac rehabilitation for people with ventricular assist devicesTolvaptan: A Novel Diuretic in Heart Failure ManagementCardiac sarcoidosis-state of the art reviewTargeting matrix metalloproteinases in heart disease: lessons from endogenous inhibitorsHeart failure in sub-Saharan Africa: review of the aetiology of heart failure and the role of point-of-care biomarker diagnosticsScope of heart failure hospitalizationEffects of an interactive CD-program on 6 months readmission rate in patients with heart failure - a randomised, controlled trial [NCT00311194]Anti-remodeling effects of rapamycin in experimental heart failure: dose response and interaction with angiotensin receptor blockadeAlcoholic cardiomyopathy : The result of dosage and individual predispositionThe evolving landscape of quality measurement for heart failureHeart failure with preserved ejection fraction.Impaired natriuretic and renal endocrine response to acute volume expansion in pre-clinical systolic and diastolic dysfunction.Diabetic cardiovascular disease: getting to the heart of the matter.Diagnostic value of patterns of symptoms and signs of heart failure: application of latent class analysis with concomitant variables in a cross-sectional study.ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.Cardiac magnetic resonance assessment of dyssynchrony and myocardial scar predicts function class improvement following cardiac resynchronization therapy.Age-related pulmonary crackles (rales) in asymptomatic cardiovascular patients.Role of echocardiography in diagnosis and risk stratification in heart failure with left ventricular systolic dysfunction.Smoking water-pipe, chewing nass and prevalence of heart disease: a cross-sectional analysis of baseline data from the Golestan Cohort Study, Iran.Clinical implications of chronic heart failure phenotypes defined by cluster analysis.Peak myocardial acceleration during isovolumic relaxation time predicts the occurrence of rehospitalization in chronic heart failure: data from the Daunia heart failure registry.Prevalence of guideline-directed medical therapy among patients receiving cardiac resynchronization therapy defibrillator implantation in the National Cardiovascular Data Registry during the years 2006 to 2008.Comparison of a one-time educational intervention to a teach-to-goal educational intervention for self-management of heart failure: design of a randomized controlled trialBeta-2 adrenergic receptor gene polymorphisms Gln27Glu, Arg16Gly in patients with heart failure.Additional Prognostic Value of EAS index in predicting the occurrence of rehospitalizations in chronic heart failure: data from the Daunia Heart Failure Registry.Effect of home-based telemonitoring using mobile phone technology on the outcome of heart failure patients after an episode of acute decompensation: randomized controlled trial.N-terminal pro-B-type natriuretic peptide as a diagnostic test for ventricular dysfunction in patients with coronary disease: data from the heart and soul studyBiventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.Cell therapy in congestive heart failure.Systemic delivery of adult stem cells improves cardiac function in spontaneously hypertensive rats.Chronic kidney disease increases cardiovascular unfavourable outcomes in outpatients with heart failure.Biomarkers and echocardiographic predictors of myocardial dysfunction in patients with hypertension.Natriuretic Peptide testing in primary careDigoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data.Chagas cardiomyopathy in the context of the chronic disease transition.Nuclear Factor (NF) kappaB polymorphism is associated with heart function in patients with heart failure.
P2860
Q21284678-35C259FB-E96F-4095-8D0B-1F8AA24D8839Q24241045-6F06FA74-004F-4FA9-B34D-D00A982A318FQ24647087-FBE096ED-9846-472D-81CA-D9D2D26E5057Q24656131-19D26B65-0C8E-49B7-B14C-BD0BCBAD605FQ26471797-9DF8982F-730D-4372-A382-C426A36B0C78Q26741174-71870D70-D085-41C8-AF3F-FA007F57B9F7Q26765213-2019646F-B337-4A04-8C78-2D87D33A7510Q26830555-9C159F11-9445-42FA-AFE5-FEA4976223E2Q27015261-1592842B-4DCC-4F04-B091-3A824ADED652Q27022922-2CF96D70-AC2B-460D-838D-CA80E3AE870CQ28219440-5CE7838F-58AE-4B3F-8E28-B46DACDD9F04Q28535743-C04C2A67-6628-44C5-BE95-90FC3250977AQ28596225-7A1B5968-341B-426D-A51E-5A69BCCB4EFEQ28680750-8D0EEB21-D910-4177-A017-A9B3B469DB3FQ30420528-DD83BE50-73D6-485D-85E2-216C4EF0346CQ30446941-E0436EED-9DD7-40F1-BF68-0D1571666610Q30451529-E5145F0F-E389-4D0E-B019-E52C62C79088Q30459347-9F0124B9-BC27-4969-9D06-B7AEE0D98B7BQ30475186-54B027E3-634B-4782-A604-580AEA322213Q30487233-52334B51-44C1-4C85-936A-1034A4A81F33Q30492837-DB7052FD-66BA-4365-B430-535ACCF847F5Q30500004-8A96BFCB-2088-4780-B030-64C91053C97EQ30582591-C925A55F-4CCC-4CFC-9BC2-2AA16252D0CCQ30604593-BD5369C7-B6FD-456A-ADC5-DCE0C1251B79Q30678040-54C8CB57-D156-47FE-9B1F-2F6BDCC66095Q30813903-17863850-29A2-4CE8-9431-6BD7DC3EAED5Q30865283-2A9D445F-6963-446C-9A75-6967D4097FCAQ30877320-B7A255BB-8A4D-4322-B718-5B3DE17CF133Q30985982-4FE96833-9C28-4F52-98E1-22EA70B449B0Q31083108-B8BC7E7B-E0A6-4D93-86E2-19448895A622Q31105305-7A481AA9-13FF-47D2-857E-29CDB6E6E30CQ33161901-695D502D-E19C-43CF-9C18-4548AD8CE309Q33295408-79FDE2BD-8C2D-426F-839C-1435682075B1Q33304571-CA2C778E-4C93-4FA9-9084-F3F65C4BB2DEQ33511547-D2258A4E-C5F0-4BF2-A15F-035E3CC2AD2DQ33559608-F76493BD-2427-4120-AA0B-E4785A66BCE6Q33572286-B3674B1B-6A49-486B-9D64-045FF3C6F3BDQ33578694-DD967DC0-4C8C-4956-8467-2938AF9F28F5Q33587293-A120BAF0-0881-4571-814D-ED4CE104CC1CQ33599397-0BE892D9-52C8-4709-8446-ED7D51D469CE
P2860
ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 G
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
ACC/AHA 2005 guideline update ...... Committee to Update the 2001 G
@ast
ACC/AHA 2005 guideline update ...... Committee to Update the 2001 G
@en
type
label
ACC/AHA 2005 guideline update ...... Committee to Update the 2001 G
@ast
ACC/AHA 2005 guideline update ...... Committee to Update the 2001 G
@en
prefLabel
ACC/AHA 2005 guideline update ...... Committee to Update the 2001 G
@ast
ACC/AHA 2005 guideline update ...... Committee to Update the 2001 G
@en
P1476
ACC/AHA 2005 guideline update ...... Committee to Update the 2001 G
@en
P2093
American Heart Association Tas ...... d Management of Heart Failure)
Sharon Ann Hunt
P356
10.1016/J.JACC.2005.08.022
P407
P577
2005-09-01T00:00:00Z